 |
 |
. . MEDICAL: DISEASES: EBOLA VIRUS : AFRICA : INDUSTRIES: PHARMACEUTICAL: Ebola Outbreak: Why Has 'Big Pharma' Failed Deadly Virus' Victims? . . Ebola Outbreak: Why Has 'Big Pharma' Failed Deadly Virus' Victims? Because, says a leading scientist, there was 'no business case' for a vaccine Charlie Cooper Sunday 07 September 2014 The Independent http://www.independent.co.uk/life-style/health-and-families/ health-news/ebola-outbreak-big-pharma-failed-victims-why-9716615.html . A shorter URL for the above link: . http://tinyurl.com/mu7eunc . . The scientist leading Britain's response to the Ebola pandemic has launched a devastating attack on "Big Pharma", accusing drugs giants including GlaxoSmithKline (GSK), Sanofi, Merck and Pfizer of failing to manufacture a vaccine, not because it was impossible, but because there was "no business case". . West Africa's Ebola outbreak, which has now claimed well over 2,000 lives, could have been "nipped in the bud", if a vaccine had been developed and stockpiled sooner a feat that would likely have been "do-able", said Professor Adrian Hill of Oxford University. . A team led by Professor Hill is to begin trials of an experimental Ebola vaccine fast-tracked into development in a desperate bid to slow the spread of the virus in Guinea, Sierra Leone and Liberia. If it passes safety and effectiveness trials, 10,000 doses of the vaccine co-developed by the Britain's GSK and America's National Institutes of Health (NIH) could be used to protect health workers in West Africa by December. . However, Professor Hill said that the fact that a vaccine had not been available to stop the disease when it emerged in Guinea six months ago represented a "market failure" of the commercial system of vaccine production which is dominated by the pharmaceutical giants. . The scale of the Ebola outbreak and the devastation it is causing in terms of lives lost and social breakdown had led the World Health Organisation (WHO) to order an unprecedented acceleration of normal drug development processes. . Experts are looking at 10 different unlicensed and experimental Ebola therapy and vaccine candidates, of which the GSK/NIH vaccine is among the most promising. Regulatory processes that usually take up to 15 years have been abandoned, to fast-track drugs and vaccines into the field. . Already, the experimental drug ZMapp, developed by Mapp, a small biopharmaceutical firm in the US, has been used to treat at least seven patients four of them Westerners and has shown promising results in trials on primates. Stocks have now run out, but Mapp has been handed $25m (15m) by the US government to scale up production. . On Friday, the WHO met in Geneva to assess the options but concluded that despite the extraordinary measures, "new treatments or vaccines are not expected for widespread use before the end of 2014". . . The complete article may be read at the URL above. . . Sincerely, David Dillard Temple University (215) 204 - 4584 [log in to unmask] http://workface.com/e/daviddillard Net-Gold http://groups.yahoo.com/group/net-gold http://listserv.temple.edu/archives/net-gold.html General Internet & Print Resources http://tinyurl.com/pwyg37u COUNTRIES http://tinyurl.com/p7s2z4u EMPLOYMENT http://tinyurl.com/oxa9w52 TOURISM http://tinyurl.com/pnla2o9 DISABILITIES http://tinyurl.com/pl7gorq INDOOR GARDENING http://tech.groups.yahoo.com/group/IndoorGardeningUrban/ Educator-Gold http://groups.yahoo.com/group/Educator-Gold/ K12ADMINLIFE http://groups.yahoo.com/group/K12AdminLIFE/ The Russell Conwell Learning Center Research Guide: THE COLLEGE LEARNING CENTER http://tinyurl.com/obcj6rf Information Literacy http://tinyurl.com/78a4shn Research Guides https://sites.google.com/site/researchguidesonsites/ Nina Dillard's Photographs on Net-Gold http://tinyurl.com/36qd2o and also at http://www.flickr.com/photos/neemers/ Twitter: davidpdillard Temple University Site Map https://sites.google.com/site/templeunivsitemap/home Bushell, R. & Sheldon, P. (eds), Wellness and Tourism: Mind, Body, Spirit, Place, New York: Cognizant Communication Books. Wellness Tourism: Bibliographic and Webliographic Essay David P. Dillard http://tinyurl.com/p63whl RailTram Discussion Group From the Union Pacific to BritRail and Beyond https://groups.yahoo.com/neo/groups/railtram/info INDOOR GARDENING Improve Your Chances for Indoor Gardening Success http://tech.groups.yahoo.com/group/IndoorGardeningUrban/ SPORT-MED https://www.jiscmail.ac.uk/lists/sport-med.html http://groups.yahoo.com/group/sports-med/ http://listserv.temple.edu/archives/sport-med.html HEALTH DIET FITNESS RECREATION SPORTS TOURISM http://health.groups.yahoo.com/group/healthrecsport/ http://listserv.temple.edu/archives/health-recreation-sports-tourism.html . . Please Ignore All Links to JIGLU in search results for Net-Gold and related lists. The Net-Gold relationship with JIGLU has been terminated by JIGLU and these are dead links. http://groups.yahoo.com/group/Net-Gold/message/30664 http://health.groups.yahoo.com/group/healthrecsport/message/145 Temple University Listserv Alert : Years 2009 and 2010 Eliminated from Archives https://sites.google.com/site/templeuniversitylistservalert/ . .